<?xml version="1.0" encoding="UTF-8"?>

-<urlset xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">

<!-- created with Free Online Sitemap Generator www.xml-sitemaps.com -->



-<url>

<loc>https://o2hventures.com/</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>1.00</priority>

</url>


-<url>

<loc>https://o2hventures.com/about</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/team</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/documents</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/news</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-coverage</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/event</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/contact</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/login</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/investor-login</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/register-advisor</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/register-with-us</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/stemnovate</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/arecor</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/neophore</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog/o2h-ventures-finalists-eisa-awards-2020</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog/ai-vivo-won-the-best-innovation-in-pharma</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/cambridge-spin-out-pharmenable-raises-1-8-million</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.80</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/opal-oncology</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/sentinel-oncology</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/repositive</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/talisman-therapeutics</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/five-alarm-bio</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/oppilotech</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/phoremost</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/privitar</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/acacia-pharma</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/pharmenable</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/qkine</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/heartfelt-technologies</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/neurofenix</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/turbine</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/pencil-biosciences</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/ai-vivo</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/small-pharma-limited</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/somaserve</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/metrion-biosciences</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/deepmatter</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/oxford-drug-design</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/portfolio/exonate</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/pdfs/o2h-Venture-User-Guide.pdf</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog/ai-vivo-identifies-covid19-drugs</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/o2h-ventures-invests-in-turbine-ai</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/o2h-ventures-makes-an-investment-in-neurofenix</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/exonate-announces-collaboration-with-johnson-and-johnson</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/sunil-shah-wins-obn-award-2019</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/tax-efficiency-awards</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/o2h-ventures-makes-an-investment-in-pencil-biosciences</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/o2h-therapeutics-ai-fund-makes-investment-in-early-stage-biotech</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/sunil-shah-o2h-ventures-wins-ukbaa-angel-of-the-year</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>

-<url>

<loc>https://o2hventures.com/blog/newsflash-covid-19-o2h-ventures-biotech-therapeutics-and-ai-fund</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog/o2h-investment-in-small-pharma</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/blog/sunil-shah-the-sunday-times</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-coverage/o2h-ventures-ceo-sunil-shah-feature-british-business-bank</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/metrion-biosciences-closes-funding-round-o2h-ventures</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/register</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/reset-password</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.64</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/sunil-shah-ceo-o2h-ventures-makes-it-to-final-in-the-ukbaa-awards-2019</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/o2h-ventures-finalist-in-the-great-eisa-25th-anniversary-awards</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/stemnovate-secures-funding-from-angels-led-by-o2h-ventures</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/privitar-raises-40-million-series-b-funding-round-led-by-accel</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/news/2-off-the-initial-fee-for-the-o2h-therapeutics-and-ai-s-eis-fund</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/o2h-ventures-limited-has-now-launched-the-o2h-therapeutics-fund</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/oxford-drug-design-recieves-over-8m-in-grant-and-equity-investment</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/metrion-biosciences-closes-funding-round</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>


-<url>

<loc>https://o2hventures.com/press-releases/the-o2h-therapeutics-fund-makes-first-investment</loc>

<lastmod>2020-10-05T10:15:36+00:00</lastmod>

<priority>0.51</priority>

</url>

</urlset>